MedPath

The Effect of Intracoronary Adenosine Injection on Outcomes of Primary Percutaneous Intervention in Patients with ST-segment Elevation Myocardial Infarctio

Phase 3
Recruiting
Conditions
Acute transmural myocardial infarction of unspecified site.
ST elevation (STEMI) myocardial infarction of unspecified site
I21.3
Registration Number
IRCT20220809055645N6
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Diagnosis of STEMI in the emergency department
Having complete criteria for primary PCI
TIMI flow grade= 0-0-1
Coronary angiography
Informed consent

Exclusion Criteria

Cardiogenic shock
Complete AV block
Severe renal failure (serum creatinine> 3 mg/dL)
Need for emergency coronary artery bypass surgery
History of recurrent coronary artery disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
(Major adverse cardiac events) MACE, which in this study is a combination of cardiac death, non-fatal myocardial infarction, any re-angiogenesis and stroke, and are defined according to The Academic Research Consortium. Timepoint: Within forty days after the intervention. Method of measurement: All patients will be followed up for MACE for 40 days, either through clinic visits or telephone interviews.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath